DNAnexus, Inc.

Translate your population health vision into actionable design. Part 2 of our biobank webinar series explores how to take scientific ambition and work it into decisions about data scale, researcher workflows, governance and access.

Register: hubs.ly/Q04DdbmP0

We’re excited to reveal a new identity system, marking our evolution from processing omics results to orchestrating omics intelligence, built on a pedigree earned across the most ambitious life science programs. dnanexus.com

Tomorrow: Case study examining GLP-1 therapy responses. hubs.ly/Q04CddQ_0

Learn how the team leveraged an EHR-linked whole-genome cohort, consisting of several thousand patients to study glycemic response, side effects, & the influence of germline variants on these.

Our team demonstrates how we worked with Ovation to examine GLP-1 treatment response from an EHR-linked whole-genome cohort of several thousand patients.

Register: hubs.ly/Q04zNzjR0

#GLP1 #Pharmacogenomics #MachineLearning #Genomics #DNAnexus

Barry Wark, PhD, of Ovation and Todd Oakland, PhD, of DNAnexus will walkthrough how to incorporate real-world clinical data and omic assets for biomarker discovery, using GLP-1 response as the worked example.

RSVP: hubs.ly/Q04zNzXG0

#ASHG2026 #GLP1 #Biomarkers #Pharma